Reversible Natural Product Glycosyltransferase-Catalyzed Reactions, Compounds and Related Methods
AssigneeWisconsin Alumni Research Foundation
InventorsJon S. Thorson, Changsgeng Zhang, Byron R. Griffith
Life of this patent
Estimating the term…
Loading patent…
AssigneeWisconsin Alumni Research Foundation
InventorsJon S. Thorson, Changsgeng Zhang, Byron R. Griffith
Estimating the term…
The present invention relates to methods of use of glycosyltransferases and related novel compounds. The invention exploits the reversibility of glycosyltransferases to generate new sugars, unnatural biomolecules and numerous one-pot reactions for generation of new biomolecules having varied backbones such as enediynes, vancomycins, bleomycins, anthracyclines, macrolides, pluramycins, aureolic acids, indolocarbazoles, aminglycosides, glycopeptides, polyenes, coumarins, benzoisochromanequinones, calicheamicins, erythromycin, avermectins, ivermectins, angucyclines, cardiac glycosides, steroids or flavinoids. In preferred embodiments, the invention specifically relates to biosynthesis of anticancer (the enediyne calicheamicin, CLM), anthelmintic agents (the macrolides avermectin, ivermectin and erythromycin) and antibiotic (the glycopeptide vancomycin, VCM) natural product-based drugs developed by reversible, bidirectional glycosyltransferase-catalyzed reactions.
A method of synthesizing an independent sugar moiety A, in-situ, from a biomolecule having a sugar moiety A, the method comprising the steps of:
A method of exchanging a sugar moiety, in-situ, between (i) an independent sugar moiety B and (ii) a biomolecule having a sugar moiety A, the method comprising the steps of:
A method of generating a biomolecule A, in situ, having a sugar moiety A from a biomolecule B having the sugar moiety A, the method comprising the steps of:
A method of generating a biomolecule A having a sugar moiety A and a biomolecule B having a sugar moiety B from a biomolecule B having the sugar moiety A and a biomolecule A having the sugar moiety B comprising the steps of:
A method of generating a library of isolated glycosylated biomolecules comprising transferring a sugar moiety from a first biomolecule backbone to a second biomolecule backbone in the presence of a glycosyltransferase wherein the sugar moiety is transferred from the first biomolecule backbone to the second biomolecule backbone thereby generating a non-naturally occurring isolated glycosylated biomolecule, wherein the first or the second biomolecule backbone is an enediyne, a vancomycin, a bleomycin, an anthracycline, a macrolide, a pluramycin, an aureolic acid, an indolocarbazole, an aminglycoside, a glycopeptide, a polyene, a coumarin, a benzoisochromanequinone, a calicheamicin, an erythromycin, an avermectin, an ivermectin, an angucycline, a cardiac glycoside, a steroid or a flavinoid.
A glycoside analog of Formula I through XIV having a non-native sugar moiety,
Dependencies are inferred from the claim text.